SHL Medical, a provider of advanced drug delivery systems such as autoinjectors, has entered into a non-exclusive co-marketing partnership agreement with Lifecore Biomedical, a CDMO that offers capabilities in the development, fill and finish of complex sterile injectable pharmaceuticals in syringes and vials. Through this partnership, Lifecore becomes a member of SHL’s recently announced Alliance Management program, an initiative created to further SHL’s customer engagement with ...